Machine learning identifies metabolic signatures associated with ER-positive breast-cancer disparities
Source check: Source checked. Not independent scientific confirmation.
Finding: Untargeted plasma metabolomics and feature-selection/classification analyses identified group-associated metabolic signatures in ER-positive breast-cancer cases; selected pathway associations were examined in TCGA data. These observational associations do not establish causal drivers of racial disparities.
Technology: Boruta and recursive feature selection with random-forest classification identified group-associated metabolite signatures for downstream pathway analysis.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Feature selection and random-forest classification identified group-associated plasma-metabolite signatures and prioritized pathway analyses.
- Test and result
- Pretreatment metabolomics from 102 ER-positive breast-cancer cases and 148 controls supported group-associated signatures; selected associations were examined in TCGA cases.
- Limitation / still unknown
- The retrospective observational analyses do not establish causal mechanisms or explain individual outcomes.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10372029/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary full-text review as recorded in case evidence; record-level claim and attribution review..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.